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The role of plasma proteins in the general  protein metabolism of the body 
is one of fundamental  importance and is particularly suited to investigation 
by the newer radioisotope techniques. By feeding labeled amino acids to donor 
dogs it is possible to obtain labeled plasma proteins which in turn can be in- 
jected into  recipient  animals.  Earlier  reports  (5,  8),  using  d/-lysine  labeled 
with N 15 and C  14 were concerned only with the apparent rates of disappearance 
of plasma proteins,  the experiments being limited by low activity which did 
not permit analysis of tissues nor of excretion products derived from the in- 
jetted plasma.  The preparation  of  e-C~4-1abeled d/-lysine  with  a  specific  ac- 
tivity some 20 times greater than that of the material originally available has 
made possible a detailed study in dogs of the distribution of C  14 activity in the 
blood protein fractions and tissues as well as the excretion of C  14 in both ex- 
pired air and urine for periods up to 7 days following intravenous injection of 
single doses of labeled plasma protein.  Zeldis  and Madden  (15) have studied 
the short term fate of transfused plasma protein labeled with radioactive sulfur. 
Previous studies in this laboratory have clearly demonstrated that plasma 
proteins  introduced  parenterally  into  dogs can  supply all  the  body protein 
needs over long periods of time (2, 6, 10, 11). That this participation in body 
metabofism is accomplished without evidence of profound protein breakdown 
is attested by the relative conservation of nitrogen which occurs during  and 
after periods of parenteral plasma administration  and also by the marked dif- 
ference  in  the  behavior of plasma  protein  given  orally  or  intravenously  to 
phlothizinized  dogs (7). 
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Recent studies on the fate of intravenously administered plasma proteins, 
given usually in the form of serum albumin,  to human subjects both normal 
and with various illnesses have been reported by Albright et al.  (1), Eckhardt 
et al.  (4), and Waterhouse, Basset, and Holler (13). Measurements of conver- 
sion of plasma protein to that of protoplasm have been made on the basis of 
decreased phosphorus  or potassium  excretion  (1,  13),  the  assumption  being 
that plasma proteins, lacking potassium, phosphorus, and other ingredients of 
tissue protein, must pick these up during the process of conversion. Increased 
nitrogen excretion, ff present, is used as a measure of that amount of protein 
which is deaminized after breakdown into amino acids, and finally the differ- 
ence between these two fractions and the total amount of protein administered 
is taken as that portion which remains unchanged. These procedures undoubt- 
edly indicate over-all changes in the metabolic picture but give little if any 
clue to a state of dynamic equilibrium or fluid exchange between cell and plasma 
protein. In all the above mentioned reports the question is raised concerning 
the manner in which plasma protein is converted into tissue protein. Albright's 
group  conclude that  their  data  offer no  direct evidence for or  against  the 
hypothesis of conversion without prior breakdown  to amino  acids  although 
some indirect evidence in  its  favor is provided by their studies  on  calcium 
metabolism. Workers in this laboratory have felt for many years that a partial 
catabolism of injected plasma protein with reassembly of large aggregates to 
form other specific types of cell and tissue protein serves better to explain the 
observed facts. On the other hand Eckhardt et al. (4) claim that a slow degrada- 
tion of plasma protein with gradual release and more or less complete conserva- 
tion of amino acids precedes its utilization by organ and tissue cells. 
In the present series of experiments the quantitative determinations of C 14 
activity transfer from plasma  to  tissue  proteins  indicate  that  this  transfer 
occurs at a rate compatible with the disappearance of the labeled protein from 
the circulation and extravascular fluid. Such transfer is accompanied by the 
excretion of only very small quantities of C 14 from the lysine fraction. This 
C ~4 conservation coupled with  the repeatedly observed retention of nitrogen 
following parenteral plasma protein injection would seem to favor the theory 
of partial as opposed to complete catabolism in so far as the metabolism of 
plasma protein is concerned. 
Methods 
Descriptions of the dogs and the procedures carried out in each experiment are included 
in the individual experimental  histories below. 
Preparation 0¢ the Labeled Plasma.--(See experimental histories of donor dogs.) The d/- 
lysine-e-C  x~ fed to the donor dogs was synthesized  in the Department of Organic Chemistry, 
The University of Rochester, under the direction of Dr. R. W. Helmkamp (9). 
D/et.--The low protein diet, a sucrose, lard, bone ash mixture with added vitamins, con- 
taining 0.12 gin. N per cent was fed in amounts calculated to supply approximately 100 
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Methods pertaining to  the collection of expired carbon dioxide;  the estimation af total 
plasma protein, albumin and globulin; the preparation of red blood cells and tissues for C ~4 
analysis and the determination of C 14 activity have been reported in a previous publication (8). 
The protein content of each tissue was based on determinations of nitrogen by the Kjeldahl 
method after drying by the lyophile process and grinding. As a check, nitrogen and C 1~ deter- 
minations were made on 5 or 6 selected tissues from each dog after trichloracetic acid and 
acetone extraction. Essentially similar results were obtained by both procedures. 
Urine samples were preserved under toluene at 4°C. Total nitrogen was determined by the 
macro-Kjeldahi method  and  urea and ammonia nitrogen by  the aeration method  of  Van 
Slyke and Cullen (12). Aliquots of urine, plasma, and other fluids were prepared for C 14 assay 
by passing a  slow stream of air through the digestion flasks, warmed to about 35°C.  until 
the material was dry. 
The amino acids, lysine, glutamic acid, aspartic acid, and arginine were isolated from acid 
hydrolysates of plasma and liver protein by appropriate methods and their identity and pu- 
rity were checked by paper chromatography. 
Histories of the Experimental Animals 
Donor dog 44-10 was a  mongrel, adult, male collie.  Over a  period of 8 weeks a  moderate 
degree of protein and hemoglobin depletion was induced by a  diet almost devoid of protein 
and intermittent bleedings to a  total of 1620 ml. during the first 4 weeks and 80 ml. during 
the second 4 weeks. The plasma protein concentrations fell from 6.69 to 4.92 gin. per 100 ml., 
hemoglobin,--which initially was 16.8 gin. per 100 ml.,--fell to 9.0 gin., and rose during the 
last few weeks to 12.0 gm. per 100 ml., while the weight fell from 16.8 to 13.8 kilos. At the 
end of this depletion period a  total of 0.668 gin. of d/-lysine-e-C  14 incorporating 467 micro- 
curies was fed in two approximately equal doses on consecutive days. The labeled lysine was 
mixed with 50 gin. of ground, cooked liver and several hours later an additional 40 gin. of 
liver and 100 gin. of the low protein diet were fed. Twenty-four hours after the second lysine 
feeding the animal received 200 gin. of liver and 100 gin. of low protein diet. At 48 hours 225 
mh of blood was withdrawn into heparin to supply 135 ml. of plasma for injection into dog 
48-106 (Experiment 1). 
Donor dog 49-117 was an adult,  male, spaniel mongrel, weighing 14.0 kilos.  Protein and 
hemoglobin depletion was induced  by a  low protein diet supplemented daily with 50 gin.  of 
horsemeat and bleedings, at 3 to 4 day intervals, totalling 1050 ml., over a period of 4 weeks. 
Plasma protein concentration dropped from 5.54 to 4.33 gin. per 100 ml. and the hemoglobin 
from 16.5 to 9.2 gin. per 100 ml. The dog's weight remained constant. At the end of the de- 
pletion period the diet was changed to 100 gin. of low protein mixture plus 150 gin. of cooked, 
ground liver. On the 2nd day of this regime 229.1  rag. of dl-lysine-E-C 14 was added and on the 
3rd day 312.5 mg. of d/-lysine-E-C  14 was added to the diet. The total activity fed as lysine 
amounted to 450 microcuries. Forty hours after the second feeding of labeled lysine, 250 ml. 
of blood was withdrawn to supply 133 ml. of plasma for injection into dog 50-37 (Experiment 
2)  and 48 hours later a  second bleeding of 250 ml. supplied 137 ml. of plasma for injection 
into dog 49-131  (Experiment 3). 
Experiment 1, dog 48-106, an adult, female, mongrel hound weighing 9.0 kilos, was placed 
on a diet of low protein content equal to 100 calories per kilo for 7 days.  This was supple- 
mented  on the first 2 days with 16 gin. of horsemeat. Mter 5  days on a constant nitrogen 
intake of approximately 0.19 gin. per day during which time the urinary nitrogen output was 
relatively constant, averaging 1.13  gin. per day,  135 mh of CX4-labeled plasma from donor 
dog 44-10 was injected intravenously after the removal of  100  ml.  of  blood. The  protein 
content of the injected plasma was 7.13 gin. in which protein, 94.75 per cent of the total C 14 
activity of 3.15 microcuries was incorporated. During the next 2 days, low protein diet was 542  PAKENTERAL  LABELED  PLASMA  PROTEIN 
fed as before, and six blood samples were collected at times indicated in Table 1 for total 
protein nitrogen and C 14 analysis. 
Albumin and globulin determinations were made on the second, fourth, and sixth samples. 
Carbon dioxide was collected from the expired air during four periods of 1 hour on the 1st 
day and two periods on the 2nd day. Two 24 hour samples of urine were obtained. Urinary 
nitrogen output was not significantly increased over the baseline and the total C ~4 excretion 
was measured. After 49 hours the dog was viviperfused under light ether anesthesia with re- 
moval of 78 per cent of the circulating plasma protein and 77 per cent of circulating red cells 
in the pergusate. Aliquots of the relatively blood-free tissues listed in Table 5 were taken for 
analysis. Immediately before bleeding and labeled plasma injection the hematocrit reading, 
was 54 per cent, the estimated plasma volume 298 ml., and the plasma protein concentration 
6.07 gin. per 100 ml. At the time of perfusion the hematocrit reading had fallen to 38 per cent, 
the plasma protein concentration to 5.45 gin. per 100 ml., and the estimated plasma volume 
was 372 ml. 
Experiment 2, dog 50-37 was an adult, female, spaniel mongrel weighing 8.9 kilos. Prior to 
the injection of labeled plasma, this dog was fed low protein diet, approximately 100 calories 
per kilo for 6 days with 16 gm. of horsemeat added for 4 days.  The animal was in negative 
nitrogen balance throughout this period with an average urinary nitrogen output of 1.31 gm. 
on each of the last 2 days.  In the 7 days following labeled plasma injection the only food intake 
was the low protein diet as be/ore, with complete consumption assured by spoon feeding when 
necessary. Urinary nitrogen excretion remained fairly constant at a daily average of 1.14 gin. 
l'he body weight remained unchanged. 
After removal of 100 ml. of blood, 133 ml. of labeled plasma from donor dog 49-117 was 
injected intravenously. This contained 6.55  gin. labeled plasma protein incorporating 95.8 
per cent of the 3.91  microcuries of total C ~ activity. During  the first 48 hours seven blood 
samples were drawn at intervals indicated in Table 2, for nitrogen and C x4 determinations of 
total plasma protein, albumin and globulin. Daily samples were collected thereafter. The C ~4 
activity of measured volumes of washed, packed red blood cells was determined daily. Carbon 
dioxide from the expired air was collected for periods of 1 hour, four times during the first 24 
hours, twice during the second 24 hours, and daily from the 3rd to 6th days. All urine was 
collected, the bladder being catheterized and rinsed at the end of each period. The output of 
the 1st day was collected in 4 periods, of the 2nd day in 2  periods,  and of the remaining 5 
days for 24 hour periods. Total nitrogen, urea and ammonia nitrogen, and C 1. activity were 
determined on each urine sample. 
Seven days after the injection of labeled plasma the dog was viviperfused under light ether 
anesthesia with modified Ringer's solution plus glucose for 45 minutes. Estimated recovery of 
circulating plasma protein was 89 per cent and of red blood cells 85 per cent of the amount 
present at the time of perfusion. A complete autopsy was performed and aliquots of the rela- 
tively blood-flee tissues were taken for nitrogen and C ~4 analysis. 
The hematocrit reading which was 45.5 per cent before bleeding and plasma injection fell to 
36.9 per cent on the 7th day. Plasma protein concentration, 5.70 gm. per 100 ml. initially, re- 
mained fairly constant (see Table 2). Plasma volumes at the beginning and end of the experi- 
ment were 395 ml. and 380 ml. respectively. 
Experiment  3, dog 49-131 was a  smooth-haired, female mongrel weighing 9.75  kilos.  An 
attempt was made to produce a moderate degree of protein depletion by a combination of low 
protein diet, providing 100 calories per kilo, and 4  intermittent bleedings totalling 435 ml. 
over a period of 3 weeks. During this time the body weight fell to 8.20 kilos, the hematocrit 
reading decreased from 60 per cent to 35.5 per cent, and the plasma protein concentration from 
6.15 to 5.90 gm. per 100 ml. However, there was no significant drop in the total amount of cir- 
culating protein. During the 3 weeks before injection of labeled plasma the dog was in negative C.  L.  YIYILE, B.  G.  LAMSON, L.  L.  MILLER~ G.  H.  WHIPPLE  543 
nitrogen balance. For the final 7 days the daily nitrogen output averaged 1.58 gm. per day 
with a daily intake of less than 0.2 gm. of nitrogen. Without prior bleeding except for sam- 
piing, 137 ml. of plasma from donor dog 49-117 was injected in 12 minutes. This contained 
7.20 gm. protein incorporating 96.5 per cent of the C 14 activity of 2.8 microcuries. The sched- 
ule of blood sampling, collection of urine and of CO2 from expired air was essentially similar 
to that outlined for Experiment 2, dog 50-37. 
Following the injection of labeled  plasma,  daily  injections of normal  dog plasma  were 
given for 6 days. These injections ranging between 100 and  125 ml. contained from 6.45 to 
7.70 gm. of plasma protein for a total of 41.1 gm. This was the sole source of nitrogen intake 
except for the small amount in 180 gm. of low protein diet consumed daily throughout the 
experimental period. During this week the dog showed a slight positive nitrogen balance with 
an average daily net intake of 1.21 gm. and urinary output of 0.97 gin. nitrogen. The latter 
figure is lower than during the control period indicating some retention of nitrogen. Plasma 
TABLE  1 
Disappearance of Labeled Plasma Proteins from Circulation 
Experiment 1, dog 48-106.  135 ml. C14-labeled plasma intravenously. 
Time after injection 
1  hr. 
5  hrs. 
11  " 
23  " 
30  " 
49  " 
Plasma 
prot. 
gm./lO0 
ml. 
4.92 
5.38 
5.12 
5.18 
4.94 
5.45 
Per cent dose C~' per gin. 
Total  Plasma  Plasma 
plas. prot.  alb.  glob. 
4.13  --  -- 
3.57  3.00  3.95 
3.22  --  -- 
2.42  1.84  3.02 
2.37  --  -- 
2.10  1.76  2.65 
Alb./Glob. 
ratio- 
chem. 
0.74 
0.88 
0.90 
Alb./Glob. 
ratio-O* 
m 
0.56 
0.54 
0.47 
Total 
clrculati~ 
activity 
i05f G$~| 
oj" dos, 
80 
75 
62 
5O 
36 
protein  concentrations in  the  7 days  after  labeled  plasma  injection are listed in  Table 3. 
Plasma volume before injection was 445 ml. and terminally 470 mi. The final hematocrit read- 
ing was 34.0 per cent. At the end of the experimental period (7 days) the dog was subjected to 
viviperfusion and autopsy as  in Experiments 1 and 2. Estimated recovery of plasma protein 
was 89.5 per cent and of red blood cells 88.0 per cent of the amount estimated to be in circula- 
tion at the time of perfusion. Tissue samples for nitrogen  and C 14 analysis were taken as indi- 
rated below (Table 5). 
EXPERIMENTAL  OBSERVATIONS 
Tables  1, 2, and 3  list the pertinent data from all three experiments  relative 
to the decline in C 14 activity in total plasma proteins and in albumin and globu- 
lin fractions.  The  decline in  C 14 activity per gram  of  total  plasma  protein  in 
each instance resulted in a  decrease to approximately 50 per cent of the original 
activity during  the first 24 hours  after injection of labeled plasma.  Following 
this initial period the  C 14 concentration  of  the plasma protein decreased  more 
slowly.  In Experiment  1  (dog 48-106)  which  was  terminated  at  the end  of 2 
days  the  C ~4 per  gram plasma  protein  decreased  13  per  cent during  the final 544  PARENTERAL  LABELED  PLASMA  PROTEIN 
TABLE  2 
Disappearance ~Labded Plasma Proteinsfiom C~culati~ 
Expefiment2, dog50-37.133 ml. Ca*-labeledpl~maintravenously. 
Time after injection 
25 min. 
3 hrs. 
6  " 
12  " 
22  " 
28  " 
47  " 
3 days 
4  " 
5  " 
6  " 
7  " 
Plasma 
prot. 
gm./lO0 
ml. 
4.57 
5.05 
5.30 
5.38 
5.50 
5.50 
5.90 
5.65 
5.20 
5.03 
5.50 
5.50 
Per cent dose C  ~ per gin. 
Total  Plasma  ?lasma 
plas.  prot.  alb.  glob. 
3.30  2.36  4.10 
2.75  2.14  3.25 
2.46  2.04  2.72 
2.06  1.62  2.38 
1.78  1.60  1.91 
1.49  1.41  1.50 
1.39  1.54  1.28 
1.20  1.49  1.02 
1.18  1.26  1.07 
1.10  1.36  0.92 
0.94  1.07  0.84 
0.89  1.02  0.81 
Alb./Glob. 
ratio- 
chem. 
0.84 
0.82 
0.67 
0.70 
0.71 
0.81 
0.59 
0.63 
0.83 
0.72 
0.82 
0.83 
Alb./Glob. 
ratio-C  u 
0.48 
0.54 
0.50 
0.48 
0.58 
0.76 
0.71 
0.93 
0.94 
1.08 
1.05 
1.06 
Total 
circulating 
activity 
per cen~ 
of dose 
8O 
72 
66 
51 
45 
38 
33 
27 
23 
21 
20 
19 
Disappearance 
Experiment 3, dog 49-131. 
TABLE  3 
of Labeled Plasma Proteins from Circulation 
137 ml. C"-labeled plasma intravenously. 
Time after injection 
10 min. 
1 hr. 
5 hrs. 
10  " 
24  "* 
28  " 
2 days* 
3  "* 
4  "* 
5  ~* 
6  "* 
7  " 
Plasma 
prot. 
gm./lO0 
ml. 
5.79 
6.22 
5.95 
6.47 
6.15 
5.93 
5.80 
6.75 
7.~ 
7.66 
7.~ 
8.08 
Per cent dose C  t4 per gin. 
Total 
plas.  prot. 
3.03 
2.46 
2.23 
2.02 
1.75 
1.64 
1.49 
1.04 
0.88 
0.70 
0.60 
0.48 
Plasma 
alb. 
2.90 
2.08 
1.98 
1.77 
1.59 
1.25 
1.08 
0.89 
0.81 
0.70 
0.72 
Plasma. 
glob. 
3.02 
2.62 
2.32 
2.12 
1.80 
1.60 
1.00 
0.78 
0.61 
0.48 
0.31 
Alb./Ginb. 
ratic~ 
chem. 
0.54 
0.56 
0.55 
0.57 
0.49 
0.63 
0.64 
0.77 
0.66 
0.67 
0.72 
Alb./Glob. 
ratlo-C14 
0.51 
0.45 
0.46 
0.48 
0.43 
0.48 
0.49 
0.69 
0.87 
0.88 
1.68 
1.55 
Total 
clrculatin~ 
activity 
~er Gent 
of  dose 
99 
83 
65 
62 
48 
45 
40 
33 
28 
25 
21 
18 
* Non-labeled plasma intravenously. 
26 hours.  In Experiment  2  (dog 50-37)  the specific  C 14 activity of  the plasma 
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In Experiment 3 (dog 49-131) in the equivalent time interval the specific C  t' 
activity of the plasma protein showed a decrease of 73 per cent. This greater 
reduction of C  *~ concentration in the plasma protein in Experiment 3  was re- 
lated to 6 daily injections of unlabeled  plasma protein totalling 40 gin. asso- 
ciated with a rise in plasma protein concentration from 6.15 to 8.08 gin. per 
I00 mi. 
The C  .4 concentration of both the albumin and globulin fractions showed a 
rapid decline, comparable  to that of total plasma protein during the first 24 
hours. Subsequently the specific activity of both fractions fell more slowly but 
the decrease  in globulin  activity was  more rapid  than that of albumin. In 
Experiment 2 the C  ~4 concentration of albumin fell 37 per cent and the globu- 
lin activity 55 per cent during the last 6 days while in the same period of 
Experiment 3 the decreases in albumin and globulin activity were 57 and 83 
per cent respectively. The incomplete data for Experiment 1 indicate a drop of 
4 per cent for albumin and 12 per cent for globulin during the 2rid day. Albu- 
min/globulin ratios show relatively little change while in the two longer ex- 
periments the ratio of albumin C  ~' per 100 ml. to globulin C  14 per 100 ml. began 
to increase after remaining constant for 1 day in dog 50-37 and 2 days in dog 
49-131. The disappearance  curves of C  ~4 activity of albumin and globulin (not 
shown)  indicate that the initially higher concentration of C  ~4 in globulin be- 
comes equal to that of albumin at 36 hours in Experiment 2 and at 60 hours 
in Experiment 3. Variation in the initial albumin and globulin activities in the 
different animals is  related to differences in the C  ~4 albumin/globulin ratios 
in the donor plasma which were 0.47 for Experiment 1, 0.54 for Experiment 
2, and 0.64 for Experiment 3. 
The final column of Tables 1 to 3 lists the total circulating C  ~' activity  as per 
cent of dose at the various time intervals.  Values for Experiment 1 are based 
on calculated estimates of plasma volume while those in Experiments 2 and 3 
were derived from direct measurements of plasma volume by the dye method, 
before the injection of labeled plasma and on the 7th day. There is a close cor- 
relation between the decreases  in total circulating  activity and activity per 
gram plasma protein. 
Fig. 1 illustrates the rate of excretion of C  14 in the carbon dioxide of expired 
air following the injection of labeled plasma in the 3 experiments. The curves 
are derived by plotting the amount of C  ~4, expressed as a percentage  of' the 
total dose, contained in the carbon dioxide expired during each 1 hour collec- 
tion period,  against time. The relatively high rate of C~402 excretion during 
the first 6 hours by dogs 48-106 (Experiment 1) and 50-37 (Experiment 2) is 
attributed to the slightly higher percentage  of non-protein C  ~4 in the plasma 
received by these two animals, 5.25 and 4.20 per cent respectively, as compared 
to the plasma given to dog 49-131 which contained 3.5 per cent non-protein 
C  ~. Plasma used for Experiments 1 and 2 was the first to be withdrawn from 546  PARENTERAL  LABELED PLASMA PROTEIN 
I  !  I 
0  0  0  Q  Q  Q 
'1: 
I 
i  , 
/ 
/ 
a 
/  /  ~,-" 
f  r 
i 
Jr~ 
m  Z 
N 
C~ 
N  N  "~-  0 
cs  6  o  o  ~ 
unoH  u~d  3SOa  ~0  Z.30  W3d--~O~)  at.ldX~  m~O C. L. YUILE, B. G. LAMSON,  L. L. MTT.LER,  G. H. V~kuI'PLE  547 
donor dogs 44-10 and 49-117, 40 and 48 hours after they had been fed C"-labeled 
d/-lysine, whereas  the plasma given to dog 49-131 was obtained from donor 
49-117 after a further lapse of 48 hours when a smaller amount of non-protein 
C  ~4 would be expected.  After the 2nd day the rate of C  ~4 excretion in the ex- 
pired CO2 reached a relatively constant low level in Experiments 2 and 3. 
The urinary excretion of C  ~ in Experiment 1, dog 48-105, amounted to 0.40 
per cent of the total activity in the injected plasma during the first 24 hour 
period and 0.13 per cent from 24 to 48 hours, while data relative to C  14 excre- 
tion in the urine for Experiments 2 and 3 are shown in Fig. 2. Fractional col- 
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Fro. 2.  Excretion rate of C 1~ in urine. Experiments 2 and 3. 
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lection of urine samples during the first 48 hours indicated a rapid decrease in 
the hourly excretion rate of C  14 within the first 12 hours and a subsequent very 
slow decline. As with C1~O~ excretion this is probably related to residual non- 
protein activity and possibly to the presence of traces of d-lysine in the injected 
plasma.  In Experiment 2 the total 7 day urinary excretion of C  14 was 2.5 per 
cent of the dose, 60 per cent being accounted for by the output in the first 24 
hours and in Experiment 3 the total was 1.3 per cent of which 41 per cent ap- 
peared during the 1st day. 
The data on urinary nitrogen excretion are summarized in Table 4. It will 
be noted that in no instance does the urinary nitrogen increase significantly 
and that there is definite  conservation of nitrogen by the animal receiving 
daily plasma injections  (Experiment 3). The proportional excretion of urea and 
ammonia nitrogen (not listed)  showed no significant alteration in Experiment 548  PARENTERAL  LABELED  PLASMA  PROTEIN 
2 but fell from 75 to 60 per cent in Experiment 3. In the second to last column 
of Table 4  are listed the protein equivalents of the total nitrogen excreted 
during each experiment. Presumably most if not all of this nitrogen was derived 
from blood or tissue protein in view of the almost negligible dietary intake. 
The figures in  the final column, Table 4, raise  an interesting question  con- 
cerning the source of this urinary nitrogen, since the total amount of C  14 ex- 
creted, including the relatively large fraction lost in the first few hours after 
injection,  corresponds  to  the  activity of  considerably less  than  1  gin.  of 
TABLE 4 
Summary of Urinary Nitrogen Excretion Data 
Dog No. 
48-106 
(Expt. 1) 
50-37 
(Expt. 2) 
49-131 
(Expt. 3) 
Duration 
of 
experi- 
ment 
days 
2 
Control 
Piss.  prof. injected  urine 
N-average 
&gt$° 
7.1 
labeled--1  injec- 
tion 
6.55 
labeled--t  injec- 
tion 
7.20 
labeled--day I 
41.1 
unlabeled--6 
daffy  injections 
gm./day 
1.13 
1.31 
1.58 
Experi- 
mental 
period- 
urine 
N-average 
gm./  day 
1.35 
1.14 
0.97 
To , l 
Uur~:etpu~  equival'ent 
gm.  gm. 
2.70  16.9 
7.97  50.5 
6.80  42.5 
Plss. prot 
equivalenl 
of .total 
urinary 
Cl4 
0.12 
0.70 
0.50 
* Corresponds to highest level of plasma protein activity on 1st day of experiment. 
plasma protein in the circulation of each animal at the beginning of the experi- 
ment. This point will be discussed in more detail below. 
The relative tissue activities found in each experiment are illustrated in Figs. 
3 to 5. They are expressed as per cent administered 0 4 per gram of tissue pro- 
rein and correspond in a general way to the distribution following labeled lysine 
feeding, reported previously (8).  A notable  exception is the adrenal which is 
consistently one of the most active tissues. However, in the earlier experiments 
0 4 activity was related to total carbon content, while the present figures are 
based on nitrogen content of fat-free tissue. 
Table 5 lists the total percentage of injected C  1~ found in the various organs 
and tissues. It must be borne in mind that values include  the activity of all 
plasma proteins in the extravascular, extracellular fluid, and in any blood not C. L. YUILE,  B. G. LAMSON,  L. L. MILLER,  G. H. WHIPPLE  549 
removed by vivipeffusion, as well as the activity actually  incorporated into 
the tissue proteins. This fact must be taken into consideration in any attempt 
to estimate the actual transfer of activity to tissue proteins and it indicates 
that in the short term experiment on dog 48-105, the tissue protein activities 
shown in Fig. 3 and Table 5 are relatively much too high, since the plasma 
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FIG. 3. Dog 48-106, Experiment 1. Relative C  14 activity of blo0d-free tissues 49 hours 
after intravenous injection of CZ4-1abeled  plasma. The values shown include all extravascular 
fluid protein activity. 
protein activity at the time of perfusion of this animal was 4 to 5 times greater 
than that at the termination of Experiments 2 and 3. 
This point is further illustrated in Table 6 in which a final balance is struck 
between the  C 14 administered intravenously as labeled plasma and  the total 
activity recovered. While the bony skeleton, bone marrow, and lymphoid tis- 
sues were not included in any of the total tissue figures, determinations of skin 
and areohr tissues were omitted in Experiment 1. The sum of these two items, 
calculated from estimates of total organ weight as a percentage of body weight, 
accounted for'about 16 per cent of the activity in Experiments 2  and 3. The 
figures for plasma and perfusate represent 78,  89, and 89.5 per cent of the es- I- 
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[XPT.  2,  004  50-37 
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FIo. 4.  Dog 5037, Experiment 2. Relative C  14 activity of blood-free tissues 7 clays after 
intravenous injection of C"-labeled plasma. Extravascuiar fluid protein activity is included. 
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FIo. 5.  Dog 49-131, Experiment 3. Relative C  14 activity of blood-free tissues 7 days after 
intravenous injection of C14-1abeled  plasma. Extravascular fluid protein activity is included. 
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timated circulating plasma protein activity in Experiments  1, 2,  and 3 respec- 
tively. 
An attempt to measure  the activity in a  small sample of red blood ceils at 
the end of Experiment 1 was unsatisfactory. However, in the two longer experi- 
ments  larger  samples  were  used  and  a  definite  pattern  emerged.  Very little 
activity was detected at 24 hours and at 48 hours it was less than 0.01 per cent 
TABLE 5 
Total 0 4 Tissue Recwoery after Intravenous  Injection of Labeled Plasma 
Source of C  I' 
Heart ............................. 
Lungs  ............................. 
Spleen  ............................. 
Stomach  ........................... 
Duodenum  ......................... 
Jejunum  ........................... 
Ileum ............................. 
Colon ............................. 
Pancreas ........................... 
Liver  .............................. 
Adrenals ........................... 
Kidneys ........................... 
Salivary glands ..................... 
Thyroid ........................... 
Skeletal muscle ..................... 
Skin ............................... 
Brain .............................. 
Uterus  ............................. 
Testes ............................. 
Fat ............................... 
Per cent administered C  I' 
Dog 48-106  Dog 50-37  Dog 49-131 
(49 hrs.)  (7 days)  (7 days) 
0.64 
0.88 
0.25 
1.82 
0.60 
1.57 
2.36 
0.12 
7.62 
0.06 
0.85 
21.90 
0.10 
0.73 
0.68 
0.32 
0.85 
0.31 
0.66 
1.47 
0.50 
0.19 
7.20 
0.03 
0.56 
0.07 
0.04 
22.60 
13.80 
0.28 
0.69 
1.12 
0.78 
1.14 
0.36 
1.11 
1.80 
0.61 
0.22 
7.05 
0.02 
0.79 
0.12 
28.75 
12.60 
0.21 
0.18 
2.45  4.10 
Total ............................  38.77  52.74  61.65 
of the dose per gin. hemoglobin. During the next 5 days there was a progressive 
apparently linear  increase  to a  level of about 0.08 per cent administered  C 14 
per gin. hemog]obin. This was approximately equal to that of the lower inter- 
mediate  tissue activities  and on the basis of total circulating hemoglobin ac- 
counted for about 4 per cent of the dose, as seen in Table 6. 
The four amino acids, lysine, glutamic acid, aspartic acid, and arginine, were 
separated from hydrolysates of plasma and liver protein from each of the three 
dogs,  the  plasma  proteins  being  precipitated  from the  fluid  removed  at  the 
time of vivipeffusion.  In each instance  the specific activities  of glutamic and 
aspartic  acid  derived  from plasma  protein  were  less  than  1  per  cent  of the 552  PARENTERAL  LABELED  PLASMA  PROTEIN 
specific activity of lysine from the same source while no significant activity was 
detected in any of the plasma arginine samples. Of the four amino acids isolated 
from liver protein only lysine contained measurable C" activity. If the specific 
activities of the other amino acids in the liver protein in relation to lysine 
activity were proportional to those found in plasma protein, detectable activity 
would not be expected in samples small enough to use in the C" measuring ap- 
paratus, and no significant activity was found on measurement. Ratios of C" 
specific  activity of lysine to total protein were approximately equal for both 
plasma and liver in each experiment. 
TABLE  6 
Total C  a4 Recovery after Intravenous  Injection of Labeled Plasma Protein 
Source of C  t4 
Tissue~  ........................... 
Plasma and perfusate  ............... 
Plasma removed in sampling ........ 
Expired CO2 ...................... 
Urine ............................. 
Red blood cells  .................... 
Experiment I  Experiment 2  Experiment 3 
Dog 48-106  Dog 50-37  Dog 4~151 
49 hrs.  7 days  7 days 
Per cent administered C14 
38.77* 
~.50 
5.~ 
5.20 
0.50 
52.74 
16.00 
5.60 
6.73 
2.50 
4.00 
61.65 
16.70 
7.90 
4.92 
1.31 
4.33 
Total recovery ....................  84.77  87.57  96.81 
* Brain, bone marrow, skeleton, integument, colon, lymphoid, and areolar  tissues not 
sampled. 
:~ C 14 activity in 1 ml. packed red blood cells insignificant. 
DISCUSSION 
The data presented relative to the disappearance rates of C  14 activity from 
the total protein, albumin and globulin, of the plasma following labeled plasma 
injection confirm the previously reported observations of a rapid initial decline 
followed by a slower phase during which the specific activity of globulin falls 
more rapidly than that of albumin (8).  It has been suggested, on the basis of 
the 50 per cent drop in specific activity of the total protein as well as of the 
albumin and globulin fractions during the first 24 hours, that equilibrium is 
reached during this time largely by simple mixing with a  quantity of protein 
in the extravascular, extracellular fluids qualitatively similar to and approxi- 
mately equal to the circulating plasma proteins. 
Added confirmation that such an estimate of the mass of non-circulating 
plasma protein at any given time is reasonably correct is obtained from Experi- 
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of the 6 days immediately following the administration of labeled plasma. The 
combined plasma protein in these 6 injections  amounted to 41.1 gin.  On the 
final day of the experiment  the specific activity of this dog's plasma proteins 
had fallen to 28 per cent of that found on the 2nd day, as contrasted with a 
decline of 50 per cent during the same time interval of Experiment 2 (dog 50-37) 
in which only a single injection of labeled plasma was given.  A summation of 
the estimated metabolic utilization of the plasma protein added in each injec- 
tion, based on the observed  rate of disappearance  of labeled protein and the 
assumption that equilibrium  is reached within 24 hours with a mass of plasma 
protein roughly twice the size of that in circulation,  indicates  that  approxi- 
mately 15 gin. would remain in the circulation  on the 7th day. The estimated 
total circulating  plasma protein at this time was 38 gin. and the specific C  14 
activity was slightly more than half that observed on the same day in dog 50-37 
which had received no additional plasma by vein. This would represent a dilu- 
tion by unlabeled plasma of about 17 gin. The fact that this figure corresponds 
closely to that derived by the above calculation lends strength to the assump- 
tions on which the calculation was based. 
It has been shown in human subjects that repeated injections  of serum al- 
bumin may increase the volume of extravascular, extracellular fluid to a degree 
proportionally greater than that occurring in the circulating plasma (14). While 
such a shift due to repeated plasma injections in Experiment 3 might have in- 
creased the total protein content of the extravascular fluid to some extent it 
would not have affected the dilution of C  14 in the plasma proteins remaining 
in equilibrium  in the two compartments. 
In the two longer experiments  the magnitude of C  14 activity transfer from 
plasma proteins to tissue proteins can be stated with reasonable accuracy. The 
total tissue activity values shown in Table 5, of 52.7 per cent for Experiment 
2 and 61.7 per cent for Experiment 3 include in addition to C  14 activity actually 
in protoplasm all the activity of proteins  in  solution  in the extravascular, 
extracellular fluid as well as small amounts of residual circulating plasma pro- 
tein activity not removed by perfusion. As previously discussed, it would seem 
justifiable  to assume that the extravascular protein portion of the total body 
activity is at least equal to the activity in the circulating plasma. By applying 
the necessary corrections the total maximum net tissue activities are therefore 
33.2 and 41.0 per cent of the administered C  ~4 in Experiments 2 and 3 respec- 
tively. 
Approximately similar figures for tissue activity can be arrived at by a dif- 
ferent type of calculation.  In Experiment 2 (dog 50-37), roughly 23 per cent 
of the dose disappeared  from the circulation  during the last 6 days of the ex- 
periment and presumably a  similar amount was removed from the extravas- 
cular fluid compartment making a total of 46 per cent. During this time about 
12 per cent of the administered C  14 could be accounted for by incorporation 554  PAI~NTERAL  LABELED  PLASMA  PROTEIN 
into red blood cells, excretion, and sampling, leaving 34 per cent for conversion 
into protoplasm.  In Experiment 3 (dog 49-131), with a loss of approximately 30 
per cent of the injected activity from the circulation during the last 6 days and 
13 per cent accounted for by red cell incorporation,  excretion, and sampling, a 
figure of 47 per cent for tissue conversion is obtained. These values are in the 
same range as those arrived at by subtracting the activity found in circulation 
at the time of perfusion from the activity of all the tissues measured.  One is 
still left in doubt about the cause of the difference in net tissue activities in 
the two 7 day experiments. The somewhat higher over-all tissue activity in the 
animal which received daily plasma protein injections  could be due either to 
increased  conversion  of plasma to tissue  protein or  to an increase  in  total 
"lymph" protein activity associated  with a shift of fluid to the extravascular 
compartment. In view of the incomplete tissue data for Experiment 1 as well 
as the much greater plasma to tissue activity ratio after only 2 days it is im- 
possible-to make any accurate estimate of actual tissue incorporation  although 
an absolute maximum would appear to be approximately 9 per cent. 
While  the above figures indicate the total conversion  of plasma to tissue 
protein in a given period of time they provide little information regarding the 
rate at which  such transfer occurs. By computing the percentage decline in 
circulating  activity for each 24 hour period after the 1st day it is found that 
smaller and smaller proportions of the total circulating activity leave the plasma 
as time goes on. In Experiment 2, 20 per cent of the activity in circulation at 
24 hours had disappeared by 48 hours while the rate of removal during the 7th 
day was only 5 per cent. Corresponding figures for Experiment 3 associated with 
daily plasma injections were 20 and 13 per cent. Differences in the rate of con- 
version  of plasma protein to protoplasm are probably related to a variety of 
factors such as the state of protein repletion,  the presence or absence of other 
substrates, and possibly the influence of certain hormones. 
The relative tissue activities shown in Figs. 4 and 5 indicate that in general 
those organs which would be expected to have the greatest metabolic activity 
are found to have the highest C  14 activity per gram of protein. The rough paral- 
lelism between  the degree of activity found in any given organ or tissue and 
the reported values for protein concentration of lymph from the same organ 
or tissue (3) suggests a relationship between these two factors. It is difficult to 
arrive at more than a relative idea of the specific activities of tissue proteins 
in the short term experiment,  Fig. 3, in view of the relatively high activity of 
plasma and "lymph" protein, which undoubtedly accounts for a considerable 
proportion of the total observed values. In this experiment the specific activity 
of plasma protein was 10 times greater than that of liver and 84 times that of 
muscle whereas  the ratios of plasma to liver protein activity were  1-5.4  in 
Experiment 2 and  1-3.5 in Experiment 3.  Corresponding  plasma to muscle 
ratios were 1-42 and 1-15. It is interesting to note that, despite the low specific C°  L°  YUILE~ B°  G°  LAMSON, L.  L.  MILLER~ G.  H.  WHIPPLE  555 
activity of muscle protein, the total muscle mass accounts for the highest in- 
dividual percentage of administered  C  14 after 1 week. 
A final point of discussion concerns the mechanism of transfer of C  1~ activity 
from plasma protein to tissue protein. There has never been any serious con- 
troversy about the quantitative  difference  between the utilization  of oral or 
parenteral  protein.  However, opinions  differ  sharply regarding  the degree to 
which plasma proteins must be degraded within the body before they become 
available to cells and tissues.  While the present experiments do not provide a 
final answer to the question, several points are worthy of note. Within a period 
of 7 days, 30 to 40 per cent of the C  ~4 activity of intravenously injected plasma 
protein,  tagged with  radioactive lysine,  is  incorporated  into  the  tissue  and 
organ proteins of dogs.  This conversion is accompanied by the loss in either 
urine or expired air of only a small fraction of administered C  14, even when the 
excretion of activity in  the first 12 hours,  related to non-protein  C  ~4 in the 
injected plasma is taken into consideration. The activity remains in the lysine 
residue of the liver proteins as demonstrated, and very probably of other pro- 
teins, and the ratio of lysine activity to total protein activity in liver and plasma 
is unaltered.  The very considerable amount of urinary nitrogen,  in terms of 
protein catabolized, excreted by these dogs in 7 days compared with the in- 
significant  quantity of C  ~4 in  the urine suggests either that  this  nitrogen  is 
derived from as yet unlabeled protein, from tissue or red cell breakdown, or 
that the lysine released from plasma and tissue proteins is almost completely 
conserved as such.  In view of the relatively high content of C  14 in the expired 
air following oral feeding of labeled plasma or tracer doses of l-lysine added to 
a  casein digest  (data to be published) it is difficult  to believe that  complete 
breakdown to the amino acid level at a rate sufficient  to account for the ob- 
served transfer of C  ~4 from plasma to tissues could occur without a greater de- 
gree of C  14 loss. 
It may be worth while to summarize our belief relative to the dynamic equilib- 
riurn which  obtains between the plasma protein and cell protein. When a dog 
is maintained  (11) in active health and normal weight for 3 months by being 
given" carbohydrate, fat, and accessories  by mouth and whole dog plasma by 
vein, it seems that the plasma proteins must supply all the protein requirements 
of the body. There is no excess of urinary nitrogen  to indicate any unusual 
protein breakdown. Liver cells can manufacture and release  albumin, fibrino- 
gen, and probably many other related proteins. If these large molecules pass 
o~t through the cell membrane there is no reason to suppose that large protein 
molecules cannot pass into  the cell through  the cell membrane when plasma 
proteins supply body needs under the conditions noted above. Labeled pro- 
teins containing C  ~4 are found in all tissue cells. 
It appears that  the problem is pushed back into  the cell--for example the 
liver cell--in  this  study of protein  equilibrium.  There  are no known  forces 556  PARENTERAL  LABELED  PLASMA PROTEIN 
outside  the cell capable of significant protein degradation and, or protein con- 
strnction in the dog. This shift of plasma proteins  to cell proteins of various 
types in various organs--liver, adrenal, muscle,  and so on--means  production 
of a  great variety of substances of protein  nature.  At present some workers 
think that the plasma proteins are degraded on the cell surface or within the 
cell to amino acids but one might suggest the possibility of more nitrogen es- 
cape in the urine under such assumed  conditions.  We prefer to think  of the 
cell as effecting  this shift of one protein to another by a less  drastic cleavage 
and reassembly; polypeptide size being concerned or cleavage of that order. 
One need not apologize  for differences of opinions  regarding processes  that 
go on in relation to the cell. In the  maelstrom which is the functioning liver 
cell so very little is known about the complex processes which bring into being 
so very much new protein material. 
SU~rl~ARY 
Labeled plasma proteins obtained from donor dogs, previously fed E-C14-dl  - 
lysine, have been given intravenously to recipient dogs. 
The disappearance of labeled globulin from the plasma at a rate considerably 
faster than albumin has been confirmed. 
Evidence suggesting  that the mass of protein in solution in the extravascular, 
extracellular fluid is approximately equal to the plasma proteins in circulation 
has been derived from a study of the dilution of labeled plasma protein by re- 
peated injections of non-labeled plasma protein. 
In  a  period of 7 days the transfer  of C  1. from plasma  to  tissue proteins 
amounted to between 30 and 40 per cent of the activity in the labeled plasma 
protein  injected intravenously.  The  conversion was  accompanied by a  very 
small loss of activity in the urine and expired air and  the activity remained in 
the lysine residue of the liver and probably of other tissues. 
The data presented favor the view that plasma proteins are utilized in the 
body economy after partial  catabolism within  the cell area and  provide no 
evidence of complete breakdown to the amino acid level. 
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